Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02694822
Title AGEN-1884, an Anti-CTLA-4 Antibody, in Advanced Solid Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Agenus Inc.
Indications

Advanced Solid Tumor

lymphoma

Therapies

Zalifrelimab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.